New trial aims to stop oral lesions from turning into cancer

This study looks at the best way to treat people with p53-mutant oral dysplasia (abnormal cells in the mouth) and early-stage oral cancer. About 636 adults will be placed into three groups based on their diagnosis and receive either monitoring, surgery, or surgery plus neck dissection. The goal is to see which approach best prevents the disease from getting worse or coming back.